---
title: "Bank of America Securities Keeps Their Sell Rating on Myriad Genetics (MYGN)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292472495.md"
description: "Bank of America Securities analyst Michael Ryskin maintained a Sell rating on Myriad Genetics (MYGN) with a $4.00 price target. TipRanks also announced the launch of the NYSE-listed ETF RANK, which tracks the TipRanks US Momentum Analysts Index. While Ryskin holds a 4-star status, the broader analyst consensus for Myriad Genetics remains Hold with an average price target of $6.80."
datetime: "2026-07-13T10:16:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292472495.md)
  - [en](https://longbridge.com/en/news/292472495.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292472495.md)
generator: "portal-rs"
---

# Bank of America Securities Keeps Their Sell Rating on Myriad Genetics (MYGN)

In a report released today, Michael Ryskin from Bank of America Securities maintained a Sell rating on Myriad Genetics, with a price target of $4.00.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

According to TipRanks, Ryskin is a 4-star analyst with an average return of 3.1% and a 53.45% success rate. Ryskin covers the Healthcare sector, focusing on stocks such as Danaher, Icon, and Idexx Laboratories.

Myriad Genetics has an analyst consensus of Hold, with a price target consensus of $6.80.

### Related Stocks

- [MYGN.US](https://longbridge.com/en/quote/MYGN.US.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [DHR.US](https://longbridge.com/en/quote/DHR.US.md)
- [ICLR.US](https://longbridge.com/en/quote/ICLR.US.md)
- [IDXX.US](https://longbridge.com/en/quote/IDXX.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)
- [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md)
- [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md)
- [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md)
- [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md)
- [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md)
- [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md)
- [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md)
- [8648.JP](https://longbridge.com/en/quote/8648.JP.md)

## Related News & Research

- [Goldman Sachs Keeps Their Hold Rating on Royal UNIBREW A/S (0R6Z)](https://longbridge.com/en/news/292727718.md)
- [Roth MKM Reaffirms Their Buy Rating on Trulite (TRUL)](https://longbridge.com/en/news/293045966.md)
- [3 Cheap Vanguard ETFs with 20%+ Upside Potential](https://longbridge.com/en/news/296641954.md)
- [AI Analyst Says These 3 ETFs Could Outperform with 10%+ Upside Potential](https://longbridge.com/en/news/296657977.md)
- [QUICK SPARK: AI Does the Stock-Picking in this New ETF](https://longbridge.com/en/news/296653331.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**